Biogen's Early-Stage Alzheimer's Data Continues to Impress Post author:Sam Post published:November 1, 2017 Post category:BioPharma ALZ’s researchers continue to see hope in Biogen’s aducanumab. Source: BioSpace You Might Also Like ERYTECH's Lead AML Drug Flunks Phase II Test December 7, 2017 These 2 Biotechs Just Won Bristol-Myers' Golden Ticket Award November 27, 2017 <b>Hip Innovation Technology</b> Initiates Clinical Trial Of Its Novel Hip Replacement System For The Treatment Of Total Hip Arthroplasty August 8, 2017
<b>Hip Innovation Technology</b> Initiates Clinical Trial Of Its Novel Hip Replacement System For The Treatment Of Total Hip Arthroplasty August 8, 2017
